Kannan Subramaniam

9PUBLICATIONS
30CO-AUTHORS
Psychological methodology, design and analysisMultimorbidityGene and molecular therapySocial determinants of healthCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 14, 2026
Changes in Anxiety Severity and Acceptability of Venlafaxine in Generalized Anxiety Disorder in the United States: Results From a Real-World Study.

|Mar 20, 2026
Sertraline for the Treatment of Major Depressive Disorder in the US: Effectiveness and Acceptability in Real-World Practice.

Christoph U Correll, Pradeep Purushottamahanti, Kannan Subramaniam

|Oct 31, 2025
A Review of the Impact of Platform Therapies (DMTs) on Associated Clinical Symptoms of Multiple Sclerosis.

Santosh B Shirol, Kannan Subramaniam, Tjalf Ziemssen

|Jul 07, 2023
Bridging the "Know-Do" Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation Science.

James F Donohue, J Stuart Elborn, Peter Lansberg

|Jun 14, 2021
The impact of COVID-19 on the care of people living with noncommunicable diseases in low- and middle-income countries: an online survey of physicians and pharmacists in nine countries.

Chris Bullen, Jessica McCormack, Amanda Calder

|Feb 05, 2021
A Methodology for Mapping the Patient Journey for Noncommunicable Diseases in Low- and Middle-Income Countries.

Tanaya Bharatan, Ratna Devi, Pai-Hui Huang

Pageof 2

Frequent Collaborators

4 joint publications

Sita Ratna Devi Duddi

2 joint publications

Pradeep Purushottamahanti

2 joint publications

Emily O C Palmer

2 joint publications

Christoph U Correll